The upcoming May regulatory calendar appears relatively light, with only five key FDA decisions expected. Despite the limited number of events, the slate includes several potentially meaningful label expansions across major therapeutic areas.
Let's take a closer look at what's ahead for the month.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.